Baipusaisi disclosed its 2026 semi-annual report on August 29. In the first half of the year, total operating revenue reached 500 million yuan, up 28.97% year-on-year; net profit attributable to the parent company was 98.3562 million yuan, up 17.36% year-on-year; non-GAAP net profit was 89.8339 million yuan, up 6.78% year-on-year. Net cash flow from operating activities was 96.3915 million yuan, up 25.71% year-on-year. Basic earnings per share were 0.5883 yuan, and the weighted average return on equity was 3.63%, up 0.43 percentage points year-on-year. As of the end of the first half, the company's inventory book value was 277 million yuan, accounting for 10.43% of net assets, with an inventory write-down provision ratio of 33.96%.
Acrobiosystems Co.Ltd.Net profit up 17.36% and revenue up 28.97% in H1 2026.
Beijing Scitop Bio Tech Co Ltd